Lepsytam 500 mg/5 ml (Oral Solution)
50 ml bottle: ৳ 200.00
Medicine Details
Category | Details |
---|---|
Generic | Levetiracetam |
Company | Healthcare pharmaceuticals ltd |
Also available as |
MedicineProduct
- Title: Lepsytam Antiepileptic Medicine
- Categories:
- Antiepileptic Drugs
- Description:
- Adjunct anti-epileptic drug for treatment of partial-onset seizures with or without secondary generalization
- Monotherapy for partial-onset seizures in adults and adolescents
- Dimensions:
- TabletSize: Varied dosages
- OralSolutionVolume: For children and infants
- TabletFormulation: Not adapted for infants and children under 6 years
- ColorOptions:
- Functions:
- Indications: Treatment of myoclonic seizures in adults and adolescents with Juvenile Myoclonic Epilepsy
- Administration: Orally, swallowed with liquid, administered in two divided doses
- Materials:
- ActiveSubstance: Levetiracetam
- Excipients: Pyrrolidone derivatives
- TechnicalSpecifications:
- RecommendedDoseAdults: 250mg twice daily initially, increased to 500mg twice daily after two weeks
- MaximumDose: 1500mg twice daily
- PediatricDose: Oral solution preferred for infants and children under 6 years
- DesignElements:
- UsabilityFeatures:
- StorageConditions: Cool temperature not exceeding 25°C, protected from light
- Interaction:
- AntiepilepticMedication: Minimal influence on serum concentration of existing antiepileptic drugs
- MethotrexateInteraction: Potential impact on methotrexate clearance, requiring careful monitoring
- Contraindications:
- Hypersensitivity to the active substance or other pyrrolidone derivatives
- SideEffects:
- AdultPatients:
- Somnolence
- Asthenia
- Infection
- Dizziness
- PediatricPatients:
- Fatigue
- Aggression
- Nasal congestion
- Decreased appetite
- Irritability
- AdultPatients:
- PregnancyAndLactation:
- PregnancyUse: Not recommended unless clinically necessary
- Breastfeeding: Not recommended, excreted in breast milk
- PrecautionsAndWarnings:
- RenalImpairment: May require dose adjustment
- BloodCellCounts: Complete blood cell counts advised at the beginning of treatment
- SuicideRisk: Patients should be monitored for signs of depression and suicidal ideation
- SpecialPopulations:
- ElderlyUse: Dose adjustment recommended for compromised renal function
- RenalImpairment: Individualized dose according to renal function
- HepaticImpairment: No dose adjustment needed in mild to moderate impairment
- OverdoseEffects:
- Symptoms:
- Somnolence
- Agitation
- Respiratory depression
- Coma
- Treatment: Symptomatic, may include haemodialysis
- Symptoms:
- TherapeuticClass: Adjunct anti-epileptic drugs